HeartSciences Inc.
Income Statement
| Line Item | Jul 2026 | Jun 2026 | Mar 2026 | Jan 2026 | Dec 2025 | Dec 2025 | Oct 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | — | — | $2.4K | — |
| Cost of Revenue | — | — | — | $0 | — | — | $1.0K | — |
| Gross Profit | — | — | — | $0 | — | — | $1.4K | — |
| Gross Margin | — | — | — | — | — | — | 58.3% | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | $638.6K | — | — | $727.0K | — |
| SG&A Expense | — | — | — | $1.3M | — | — | $1.3M | — |
| Operating Income | — | — | — | $-1.9M | — | — | $-2.1M | — |
| Operating Margin | — | — | — | — | — | — | -85,713.2% | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | $-2.0M | — | — | $-2.4M | — |
| Net Margin | — | — | — | — | — | — | -97,179.4% | — |
| EPS (Basic) | — | — | — | $-0.21 | — | — | $-0.28 | — |
| EPS (Diluted) | — | — | — | — | — | — | $-0.28 | — |
| Shares Outstanding (Basic) | 3.9M | 3.2M | 9.6M | 9.5M | 3.4M | 9.5M | 8.3M | 7.9M |
| Shares Outstanding (Diluted) | 3.9M | 3.2M | 9.6M | 9.5M | 3.4M | 9.5M | 8.3M | 7.9M |
| Dividends Per Share | — | — | — | — | — | — | — | — |